Concepedia

Johannes vom Berg

JV

20

Publications

1.6K

Citations

16

H-Index

2007

Active since

Affiliations

University of Zurich(Current)

ETH Zurich

Ludwig-Maximilians-Universität München

University Hospital of Basel

Center for Integrated Protein Science Munich

Johannes vom Berg is an author at University of Zurich specializing in medicine, cell biology, and neuroinflammation.

ORCID

Top concepts

Publications per year

2007–2023

20

Publications

20

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline

Johannes vom Berg, Stefan Prokop, Kelly R. Miller et al. · Nature Medicine · 2012 · 403 citations

, , +14

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection

Johannes vom Berg, Melissa Vrohlings, Sergio Haller et al. · The Journal of Experimental Medicine · 2013 · 221 citations · Full text

IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46

Maya Eisenring, Johannes vom Berg, Glen Kristiansen et al. · Nature Immunology · 2010 · 209 citations

, , +12

Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models

Marcel Schneider, Laura Heeb, Michał Beffinger et al. · Science Translational Medicine · 2021 · 159 citations

Enzymatic Dissociation Induces Transcriptional and Proteotype Bias in Brain Cell Populations

Daniele Mattei, Andranik Ivanov, Marc van Oostrum et al. · International Journal of Molecular Sciences · 2020 · 132 citations · Full text

, , +16

Rows per page

1–5 of 20